Teva Pharmaceuticals Industries Ltd. reduced last week its guidance for 2012 earnings by at least 18 cents per share. Photographer: Adam Reynolds/Bloomberg
Teva Pharmaceuticals Industries Ltd. reduced last week its guidance for 2012 earnings by at least 18 cents per share. Photographer: Adam Reynolds/Bloomberg
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=222532545&utmp=%2Fphoto%2F2012-05-28%2Fteva-has-longest-rout-since-november-israel-overnight&utmhn=10.248.179.17&utmac=UA-11413116-12&utmhid=198293746)